Kindstar Globalgene Technology Inc
HKEX:9960
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kindstar Globalgene Technology Inc
HKEX:9960
|
CN |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
Atlas Copco AB
OTC:ATLCY
|
SE |
|
Brinker International Inc
NYSE:EAT
|
US |
|
T
|
Telecom Digital Holdings Ltd
HKEX:6033
|
HK |
|
T
|
Tantia Constructions Ltd
NSE:TANTIACONS
|
IN |
|
BGI Genomics Co Ltd
SZSE:300676
|
CN |
|
B
|
BNP Paribas SA
XETRA:BNP
|
FR |
|
S
|
SBH Marine Holdings Bhd
KLSE:SBH
|
MY |
|
H
|
Hand Enterprise Solutions Co Ltd
SZSE:300170
|
CN |
|
VanJee Technology Co Ltd
SZSE:300552
|
CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
CN |
Kindstar Globalgene Technology Inc
Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. The company is headquartered in Wuhan, Hubei. The company went IPO on 2021-07-16. The firm operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.
Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. The company is headquartered in Wuhan, Hubei. The company went IPO on 2021-07-16. The firm operates nine segments. Hematology Testing segment includes testing services related to blood diseases. Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. Infectious Diseases segment includes testing services from the infection department. Oncology segment includes testing related to oncology diseases. Neurology segment includes testing services related to neurological diseases undertaken by the Group. Maternity-related Diseases segment includes testing services related to maternity. COVID-19 Related Testing segment includes testing services related to COVID-19. Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Others segment includes testing services for research and development (R&D) projects and others and miscellaneous services.